Monoclonal antibodies in the treatment of chronic lymphocytic leukemia

ISSN： 1357-0560

Source： Medical Oncology, Vol.21, Iss.4, 2004-12, pp. : 297-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia

By Robak Tadeusz

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 69-91

Future Medicine

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: Prognosis and Treatment Options

By Wierda William G. Keating Michael J. O'Brien Susan

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 163-178

Adis International

Access to resources Recommend Favorite

New and Repositioning Approaches to the Treatment of Chronic Lymphocytic Leukemia(

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 67-100

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 666-682

Bentham Science Publishers

Access to resources Recommend Favorite

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina Ösby Eva Lundin Jeanette Kalin Mats Österborg Anders Gruber Astrid

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite